Close Menu

NEW YORK – Medicare Administrative Contractors CGS Administrators and Wisconsin Physicians Service Insurance Corporation released final coverage decisions aligning with Palmetto's limited coverage of minimal residual disease testing in patients with colorectal cancer.

The evidence review for the decisions centered specifically on Natera's Signatera test, although other ctDNA tests that meet the requirements would also be covered.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.